Literature DB >> 26399468

The FDA's new clothes.

Donald W Light1, Joel Lexchin2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26399468     DOI： 10.1136/bmj.h4897

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Gating the holes in the Swiss cheese (part I): Expanding professor Reason's model for patient safety.

Authors:  Shashi S Seshia; G Bryan Young; Michael Makhinson; Preston A Smith; Kent Stobart; Pat Croskerry
Journal:  J Eval Clin Pract       Date:  2017-11-23       Impact factor: 2.431

Review 2.  Late translational research: putting forward a new model for developing new anti-cancer treatments that addresses the needs of patients and society.

Authors:  Denis Lacombe; Jan Bogaerts; Bertrand Tombal; François Maignen; Leeza Osipienko; Richard Sullivan; Vassilis Golfinopoulos
Journal:  Mol Oncol       Date:  2019-01-19       Impact factor: 6.603

Review 3.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25

Review 4.  Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing.

Authors:  Natalie K Boyd; Chengwen Teng; Christopher R Frei
Journal:  Front Cell Infect Microbiol       Date:  2021-05-17       Impact factor: 5.293

5.  Health and Ethical Consequences of Outsourcing Pivotal Clinical Trials to Latin America: A Cross-Sectional, Descriptive Study.

Authors:  Núria Homedes; Antonio Ugalde
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.